This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignees: Syntex (u.s.a.) Inc., Syntex Pharmaceuticals, Ltd.. Active years: 1990-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1993
Title: Alastair B Selkirk: Innovator in Pharmaceutical Composition
Introduction
Alastair B Selkirk is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of long-acting formulations for calcium channel blockers. With a total of 5 patents to his name, Selkirk's work has had a meaningful impact on medication delivery systems.
Latest Patents
One of Selkirk's latest patents is the "Long acting calcium channel blocker composition." This invention discloses an improved long-acting sustained release pharmaceutical composition for dihydropyridine calcium channel blockers. The composition features a pH-dependent binder and is designed to provide slow, sustained release of a therapeutically effective amount of the calcium channel blocker over a period of at least 24 hours. This innovation allows for once-daily administration, enhancing patient compliance. Another significant patent is the "Long acting nicardipine hydrochloride formulation," which similarly focuses on sustained release for dihydropyridine calcium channel blockers, utilizing spherically shaped non-rugose particles.
Career Highlights
Throughout his career, Selkirk has worked with prominent companies in the pharmaceutical industry, including Syntex (U.S.A.) Inc. and Syntex Pharmaceuticals, Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Selkirk has collaborated with notable professionals in his field, including Michael J Dey and Calum B MacFarlane. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical compositions.
Conclusion
Alastair B Selkirk's contributions to the field of pharmaceutical compositions, particularly in the area of long-acting formulations, demonstrate his commitment to improving medication delivery systems. His patents reflect a dedication to enhancing patient care through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile